SCHEMBL1634288

SCHEMBL1634288

C#Cc1cc(-c2ccc(NCCN3CCCC3)nc2)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.44
CA1 P00915 3/20 0.44
CA9 Q16790 3/20 0.44
CA4 P22748 2/20 0.40
CDK1 P06493 7/20 0.40
CCNT1 O60563 6/20 0.40
CCNE1 P24864 6/20 0.40
CDK2 P24941 6/20 0.40
CDK9 P50750 6/20 0.40
CDK5R1 Q15078 6/20 0.40
CDK4 P11802 4/20 0.40
CCNA2 P20248 4/20 0.40
CCND1 P24385 4/20 0.40
CCND3 P30281 4/20 0.40
CDK7 P50613 4/20 0.40
CDK3 Q00526 4/20 0.40
CDK6 Q00534 4/20 0.40
BRAF P15056 2/20 0.39
CDK5 Q00535 3/20 0.38
SRC P12931 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633540 0.89 CA1 (0.47) CA2CA1CA9CA4CDK1
SCHEMBL1633573 0.89 CA1 (0.47) CA2CA1CA9CA4CDK1
SCHEMBL12764646 0.88 CA1 (0.46) CA2CA1CA9CA4CDK1
SCHEMBL1633268 0.86 CA1 (0.44) CA2CA1CA9CA4CDK1
SCHEMBL1633149 0.86 CA1 (0.48) CA2CA1CA9CA4CDK1
SCHEMBL1633466 0.81 CA1 (0.48) CA2CA1CA9CDK1CCNT1
SCHEMBL1634792 0.81 MAPK10 (0.43) CA2CA1CA9CA4CDK1
SCHEMBL1633121 0.79 MAPK10 (0.52) CA2CA1CA9JAK2
SCHEMBL1632922 0.78 JAK2 (0.48) SRCJAK2JAK3PTK2NMT1
SCHEMBL1633492 0.77 CDK2 (0.49) CA2CA1CA9CA4CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed